Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting interleukin-2 as a treatment for psoriasis.

A Salim1, R Emerson

  • 1Department of Dermatology, North Staffordshire Hospital, Stoke-on Trent, UK. salim@doctors.org.uk

Current Opinion in Investigational Drugs (London, England : 2000)
|January 5, 2002
PubMed
Summary

Interleukin-2 (IL-2) drives psoriasis by activating T-cells. New therapies targeting IL-2 production or action offer promising treatments for this inflammatory skin condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Pigmented Lesion Referral Pathways on Melanoma Detection.

Irish medical journal·2026
Same author

Overall and area-specific tactile recovery following different methods of surgical reinnervation in post-mastectomy breast reconstruction - a systematic review and meta-analysis.

Acta chirurgiae plasticae·2026
Same author

Social support can mitigate socioeconomic disparities in trauma patients.

American journal of surgery·2025
Same author

Interferon-γ receptor-1 gene promoter polymorphisms and susceptibility for brucellosis in Makkah region.

African health sciences·2019
Same author

Is the matched extreme case-control design more powerful than the nested case-control design?

Statistical methods in medical research·2018
Same author

Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?

Clinical and experimental dermatology·2017

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Interleukin-2 (IL-2) is a critical cytokine in immune responses.
  • IL-2 signaling promotes T-cell activation, contributing to inflammatory conditions.
  • Psoriasis pathogenesis involves dysregulated T-cell activity driven by IL-2.

Purpose of the Study:

  • To review recent therapeutic strategies targeting the IL-2 pathway in psoriasis.
  • To discuss novel approaches for inhibiting IL-2 production or action.
  • To highlight the clinical relevance of IL-2 blockade in managing psoriasis.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of therapeutic mechanisms targeting IL-2.
  • Discussion of emerging IL-2-targeted therapies.

Main Results:

  • Several novel therapies effectively block IL-2 signaling.
  • These therapies demonstrate potential in reducing T-cell activation in psoriasis models.
  • Targeting IL-2 offers a specific approach to psoriasis treatment.

Conclusions:

  • IL-2 blockade represents a promising therapeutic avenue for psoriasis.
  • Targeting the IL-2 pathway provides a mechanism-specific treatment strategy.
  • Further research and clinical trials are warranted for IL-2-targeted therapies.

Related Experiment Videos